Connelly to lead Lilly’s U.S. unit, joins elite group

Share this article:
Eli Lilly yesterday named Deirdre Connelly president of Lilly USA.
The role gives Connelly direct responsibility for an affiliate that generated $7 billion in 2004 sales and has 6,600 employees.
In the process, Connelly joins an elite and growing band of female pharma execs, including Christine Poon, worldwide chairman of medicines and nutritionals at Johnson & Johnson, Karen Katen, vice chairman of Pfizer, Margaret McGlynn, president of U.S. Human Health Care at Merck, and Carrie Cox, president, global pharmaceutical business at Schering-Plough.
Connelly was promoted from the position of senior vice president for human resources, which she held only since last August. Succeeding her in that role is Anthony Murphy, formerly executive director for human resources.
She reports to John Lechleiter, executive vice president of pharmaceutical operations, who has had the additional task of leading U.S. operations since last July.
After joining Lilly's field force in 1984, Connelly held various positions, including leader of its U.S. women's health business unit and executive director of human resources for Lilly USA.
Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.